LWW Oncology | Search

Showing Results for [onc] lobular carcinoma

Narrow Results

Content Types

All (4)

Texts (3)

Images (1)

NCI Clinical Trials

Looking for trials? Go to NCI and browse 8,000+ trials

4 Search Results

Principles and Practice of Surgical Oncology

View in context

Diseases of the Breast

Chapter 24. Lobular Carcinoma In Situ: Biology and Pathology

Diseases of the Breast

Chapter 25. Lobular Carcinoma In Situ: Clinical Management

Cancer: Principles & Practice of Oncology

Chapter 106. Malignant Tumors of the Breast >

Lobular Carcinoma In Situ

In 1941 Foote and Stewart49a published their landmark study of LCIS, describing a relatively uncommon entity characterized by an “alteration of lobular cytology.” Foote and Stewart chose the name to ...

Didn't find what you were looking for?

Run a full-text search on 'lobular carcinoma'

What do you think of LWWOncology?

Share Your Feedback

More Results

Journal Results from PubMed

First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.

J. Clin. Oncol. | Mar 19, 2012

Inhibiting angiogenesis in breast cancer: the beginning of the end or the end of the beginning?

J. Clin. Oncol. | Mar 19, 2012

Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.

J. Clin. Oncol. | Dec 30, 2011

Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

J. Clin. Oncol. | Aug 31, 2011

Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.

J. Clin. Oncol. | Aug 31, 2011

View More on PubMed >